AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials.

At ASMS 2023, SCIEX launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing separation and UV detection.

Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.

TriLink’s construction of the new 32,000-square-foot, cGMP-grade facility solidifies its commitment to advancing the field as more mRNA-based therapeutics and vaccines enter later-stage clinical trials.

Cellular Origins has announced the launch of Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.

GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announced today that it is collaborating with Emery Pharma.

uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.

Form Bio announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life science companies and academic institutions.

Waters™ Corporation has completed its acquisition of Wyatt Technology, a developer of innovative light scattering and field-flow fractionation instruments, software, accessories and services.

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.